Join
Live feed
·
INSIDERFilingvia Quantisnow
First Wave BioPharma Inc. logo

Sapirstein James sold $736 worth of shares (174 units at $4.23), decreasing direct ownership by 0.47% to 37,105 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FWBI· First Wave BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FWBI (First Wave BioPharma Inc.) and more on Quantisnow.